Form EFFECT Dermata Therapeutics,
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | November 25, 2022 5:00 P.M. |
Form: | S-3 | ||||||
|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amerant Reports First Quarter 2024 Results
- Ensurge Micropower ASA - Grant of Incentive Subscription Rights
- Biophytis Announces Transfer of ADSs to OTC Market
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!